secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVRx, Inc. (CVRX)
CIK:        0001235912
Form:       8-K
Filed at:   2026-08-11T11:09:16+00:00
Accession:  0001104659-26-093721
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVRx CRO Robert John departs; Paul Verrastro named interim head of sales
------------------------------------------------------------------------

- Robert John terminated as CRO effective Aug 10, 2026; eligible for severance under employment agreement.
- Paul Verrastro named Interim Head of Sales, effective immediately; leads search for permanent successor.
- Verrastro has 30+ years med-device sales experience; former CMO at CVRx, previously Guidant, Boston Scientific, Medtronic.
- CEO Kevin Hykes cites revised commercial outlook and need to improve commercial execution for the change.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1235912/000110465926093721/0001104659-26-093721-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1235912/000110465926093721/tm2622791d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-093721

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer